TLIS vs. STAI, ASTC, PRPO, BNGO, TBIO, SMIT, SPEC, THMO, HTGMQ, and OLITW
Should you be buying Talis Biomedical stock or one of its competitors? The main competitors of Talis Biomedical include Scantech AI Systems (STAI), Astrotech (ASTC), Precipio (PRPO), Bionano Genomics (BNGO), Telesis Bio (TBIO), Schmitt Industries (SMIT), Spectaire (SPEC), ThermoGenesis (THMO), HTG Molecular Diagnostics (HTGMQ), and OmniLit Acquisition (OLITW). These companies are all part of the "measuring and control equipment" industry.
Talis Biomedical vs.
Talis Biomedical (NASDAQ:TLIS) and Scantech AI Systems (NASDAQ:STAI) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, media sentiment, risk, community ranking, dividends, profitability and institutional ownership.
43.8% of Talis Biomedical shares are held by institutional investors. Comparatively, 74.0% of Scantech AI Systems shares are held by institutional investors. 46.0% of Talis Biomedical shares are held by insiders. Comparatively, 22.8% of Scantech AI Systems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Talis Biomedical received 9 more outperform votes than Scantech AI Systems when rated by MarketBeat users.
Talis Biomedical has a beta of 1.47, meaning that its share price is 47% more volatile than the S&P 500. Comparatively, Scantech AI Systems has a beta of -0.68, meaning that its share price is 168% less volatile than the S&P 500.
Scantech AI Systems' return on equity of 0.00% beat Talis Biomedical's return on equity.
In the previous week, Scantech AI Systems had 2 more articles in the media than Talis Biomedical. MarketBeat recorded 2 mentions for Scantech AI Systems and 0 mentions for Talis Biomedical. Scantech AI Systems' average media sentiment score of 1.89 beat Talis Biomedical's score of 0.00 indicating that Scantech AI Systems is being referred to more favorably in the news media.
Scantech AI Systems has higher revenue and earnings than Talis Biomedical.
Summary
Scantech AI Systems beats Talis Biomedical on 7 of the 10 factors compared between the two stocks.
Get Talis Biomedical News Delivered to You Automatically
Sign up to receive the latest news and ratings for TLIS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Talis Biomedical Competitors List
Related Companies and Tools
This page (NASDAQ:TLIS) was last updated on 3/31/2025 by MarketBeat.com Staff
